Quantcast

Latest Cancer immunology Stories

2010-03-22 08:08:00

New research may guide creation of targeted, more effective vaccines BOSTON, March 22 /PRNewswire-USNewswire/ -- A new understanding of a certain cell in the immune system may help guide scientists in creating better flu vaccines, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston (PCMM/IDI). Reporting online March 21 in Nature Immunology, they show, for the first time, that white blood cells known as...

2010-03-22 14:58:35

New research may guide creation of targeted, more effective vaccines A new understanding of a certain cell in the immune system may help guide scientists in creating better flu vaccines, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston (PCMM/IDI). Reporting online March 21 in Nature Immunology, they show, for the first time, that white blood cells known as resident dendritic cells (DCs) capture flu viruses...

2009-12-11 16:03:25

In animal and patient studies, an experimental drug eliminated chemotherapy-resistant breast cancer stem cells "“ the cells that remain after treatment that could potentially refuel tumor growth, said researchers from Baylor College of Medicine and The University of Michigan at Ann Arbor today at the CTRC-AACR San Antonio Breast Cancer Symposium. "In previous studies, we have identified a genetic pathway "“ called the Notch pathway "“ as a top target for eliminating these...

2009-10-08 14:55:36

Older cancer sufferers need treatments tailored to their aging immune systems Elderly cancer patients need a combination of treatments tailor-made to their specific needs to successfully combat the disease. The challenge is to boost their immune response to cancer vaccines, because like the rest of our organs, our immune system ages and gradually becomes less efficient as we get older. Dr. Joseph Lustgarten, from the Mayo Clinic College of Medicine in the US, reviews the effects of aging on...

2008-10-10 00:00:10

-Paper Published in the Journal of Immunotherapy- MacDougall Biomedical Communications Jennifer Greenleaf, 781-235-3060 or Argos Therapeutics Jeff Abbey, 919-287-6308 Logo: http://www.argostherapeutics.com Argos Therapeutics today announced the publication of a paper in the October 2008 issue of the Journal of Immunotherapy demonstrating that the Company's process of maturing dendritic cells (DC) electroporated with antigen-encoded messenger RNA (mRNA) is capable of driving...

2008-10-09 09:00:52

Argos Therapeutics today announced the publication of a paper in the October 2008 issue of the Journal of Immunotherapy demonstrating that the Company's process of maturing dendritic cells (DC) electroporated with antigen-encoded messenger RNA (mRNA) is capable of driving long-term, stable expansion of cytolytic antigen-specific T cells that express effector/memory phenotype. These T cells also exhibited much higher functional activity, suggesting improved T cell avidity. This approach is...

2008-07-02 00:00:28

Scientists at Wake Forest University Baptist Medical Center say they are beginning a human cancer trial to test transfusing specific white blood cells. Lead researcher Zheng Cui announced the study at the Understanding Aging conference in Los Angeles. The study, given the go-ahead by the U.S. Food and Drug Administration, will involve treating human cancer patients with white blood cells from healthy young people whose immune systems produce cells with high levels of cancer-fighting...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related